Search Results

Safety and efficacy of mass drug administration with a single-dose triple-drug regimen...

by Livingstone Tavul, Moses Laman, Cade Howard, Bethuel Kotty, Anna Samuel, Catherine Bjerum, Kobie O'Brian, Steven Kumai, Matthew Amuga, Lina Lorry, Zebedee Kerry, Melvin Kualawi, Stephan Karl, Leo Makita, Lucy N John, Sibauk Bieb, James Wangi, Gary J Weil, Charles W Goss, Daniel J Tisch, William Pomat, Christopher L King, Leanne J Robinson
Published in PLOS Neglected Tropical Diseases (2022)

Modeling the impact and costs of semiannual mass drug administration for accelerated elimination of lymphatic filariasis.

by Wilma A Stolk, Quirine A ten Bosch, Sake J de Vlas, Peter U Fischer, Gary J Weil, Ann S Goldman
Published in PLoS Neglected Tropical Diseases (2013)

A review of factors that influence individual compliance with mass drug administration for elimination of lymphatic filariasis.

by Alison Krentel, Peter U Fischer, Gary J Weil
Published in PLoS Neglected Tropical Diseases (2013)

Transmission assessment surveys (TAS) to define endpoints for lymphatic filariasis mass drug administration: a multicenter evaluation.

by Brian K Chu, Michael Deming, Nana-Kwadwo Biritwum, Windtaré R Bougma, Améyo M Dorkenoo, Maged El-Setouhy, Peter U Fischer, Katherine Gass, Manuel Gonzalez de Peña, Leda Mercado-Hernandez, Dominique Kyelem, Patrick J Lammie, Rebecca M Flueckiger, Upendo J Mwingira, Rahmah Noordin, Irene Offei Owusu, Eric A Ottesen, Alexandre Pavluck, Nils Pilotte, Ramakrishna U Rao, Dilhani Samarasekera, Mark A Schmaedick, Sunil Settinayake, Paul E Simonsen, Taniawati Supali, Fasihah Taleo, Melissa Torres, Gary J Weil, Kimberly Y Won
Published in PLoS Neglected Tropical Diseases (2013)

The impact of repeated rounds of mass drug administration with diethylcarbamazine plus albendazole on bancroftian filariasis in Papua New Guinea.

by Gary J Weil, Will Kastens, Melinda Susapu, Sandra J Laney, Steven A Williams, Christopher L King, James W Kazura, Moses J Bockarie
Published in PLoS Neglected Tropical Diseases (2008)

Reassessment of areas with persistent Lymphatic Filariasis nine years after cessation of mass drug administration in Sri Lanka.

by Ramakrishna U Rao, Sandhya D Samarasekera, Kumara C Nagodavithana, Tharanga D M Dassanayaka, Manjula W Punchihewa, Udaya S B Ranasinghe, Gary J Weil
Published in PLOS Neglected Tropical Diseases (2017)

A comprehensive assessment of lymphatic filariasis in Sri Lanka six years after cessation of mass drug administration.

by Ramakrishna U Rao, Kumara C Nagodavithana, Sandhya D Samarasekera, Asha D Wijegunawardana, Welmillage D Y Premakumara, Samudrika N Perera, Sunil Settinayake, J Phillip Miller, Gary J Weil
Published in PLoS Neglected Tropical Diseases (2014)

Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA...

by Peter U Fischer, Christopher L King, Julie A Jacobson, Gary J Weil
Published in PLOS Neglected Tropical Diseases (2017)

A multicenter, community-based, mixed methods assessment of the acceptability of a triple drug regimen for elimination of lymphatic filariasis.

by Alison Krentel, Nandha Basker, Madsen Beau de Rochars, Joshua Bogus, Daniel Dilliott, Abdel N Direny, Christine Dubray, Peter U Fischer, Adriani Lomi Ga, Charles W Goss, Myra Hardy, Cade Howard, Purushothaman Jambulingam, Christopher L King, Moses Laman, Jean Frantz Lemoine, Shruti Mallya, Leanne J Robinson, Josaia Samuela, Ken B Schechtman, Andrew C Steer, Taniawati Supali, Livingstone Tavul, Gary J Weil
Published in PLOS Neglected Tropical Diseases (2021)

Impact of annual and semi-annual mass drug administration for Lymphatic Filariasis and Onchocerciasis on Hookworm Infection in Côte d'Ivoire.

by Agodio Loukouri, Aboulaye Méité, Benjamin G Koudou, Charles W Goss, Daphne Lew, Gary J Weil, Eliezer K N'Goran, Peter U Fischer
Published in PLOS Neglected Tropical Diseases (2020)

Systematic sampling of adults as a sensitive means of detecting persistence of lymphatic filariasis following mass drug administration in Sri Lanka.

by Ramakrishna U Rao, Sandhya D Samarasekera, Kumara C Nagodavithana, Manjula W Punchihewa, Udaya S B Ranasinghe, Gary J Weil
Published in PLOS Neglected Tropical Diseases (2019)

Community Rates of IgG4 Antibodies to Ascaris Haemoglobin Reflect Changes in Community Egg Loads Following Mass Drug Administration.

by Johnny Vlaminck, Taniawati Supali, Peter Geldhof, Cornelis H Hokke, Peter U Fischer, Gary J Weil
Published in PLOS Neglected Tropical Diseases (2016)

The safety of combined triple drug therapy with ivermectin, diethylcarbamazine and albendazole...

by Myra Hardy, Josaia Samuela, Mike Kama, Meciusela Tuicakau, Lucia Romani, Margot J Whitfeld, Christopher L King, Gary J Weil, Anneke C Grobler, Leanne J Robinson, John M Kaldor, Andrew C Steer
Published in PLOS Neglected Tropical Diseases (2020)

Safety and efficacy of co-administered diethylcarbamazine, albendazole and ivermectin during mass drug administration for lymphatic filariasis in Haiti: Results from a two-armed, open-label, cluster...

by Christine L Dubray, Anita D Sircar, Valery Madsen Beau de Rochars, Joshua Bogus, Abdel N Direny, Jean Romuald Ernest, Carl R Fayette, Charles W Goss, Marisa Hast, Kobie O'Brian, Guy Emmanuel Pavilus, Daniel Frantz Sabin, Ryan E Wiegand, Gary J Weil, Jean Frantz Lemoine
Published in PLOS Neglected Tropical Diseases (2020)

Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection...

by Constant Edi, Catherine M Bjerum, Allassane F Ouattara, Yashpal S Chhonker, Louis K Penali, Aboulaye Méité, Benjamin G Koudou, Gary J Weil, Christopher L King, Daryl J Murry
Published in PLOS Neglected Tropical Diseases (2019)

Pharmacokinetics of Moxidectin combined with Albendazole or Albendazole plus Diethylcarbamazine for Bancroftian Filariasis.

by Yashpal S Chhonker, Catherine Bjerum, Veenu Bala, Allassane F Ouattara, Benjamin G Koudou, Toki P Gabo, Abdullah Alshehri, Abdoulaye Meïté, Peter U Fischer, Gary J Weil, Christopher L King, Philip J Budge, Daryl J Murry
Published in PLOS Neglected Tropical Diseases (2023)

Adverse events following single dose treatment of lymphatic filariasis: Observations from a review of the literature.

by Philip J Budge, Carly Herbert, Britt J Andersen, Gary J Weil
Published in PLOS Neglected Tropical Diseases (2018)

Safety and tolerability of moxidectin and ivermectin combination treatments for lymphatic filariasis in Côte d'Ivoire: A randomized controlled superiority study.

by Catherine M Bjerum, Benjamin G Koudou, Allassane F Ouattara, Daphne Lew, Charles W Goss, Pascal T Gabo, Christopher L King, Peter U Fischer, Gary J Weil, Philip J Budge
Published in PLOS Neglected Tropical Diseases (2023)

Diagnostics to support elimination of lymphatic filariasis-Development of two target product profiles.

by Kimberly Y Won, Katherine Gass, Marco Biamonte, Daniel Argaw Dagne, Camilla Ducker, Christopher Hanna, Achim Hoerauf, Patrick J Lammie, Sammy M Njenga, Rahmah Noordin, Kapa D Ramaiah, Reda Ramzy, Ronaldo G Carvalho Scholte, Anthony W Solomon, Ashley A Souza, Jordan Tappero, Emily Toubali, Gary J Weil, Steven A Williams, Jonathan D King
Published in PLOS Neglected Tropical Diseases (2021)

An open label, randomized clinical trial to compare the tolerability and efficacy of ivermectin plus diethylcarbamazine and albendazole vs. diethylcarbamazine plus albendazole for...

by Taniawati Supali, Yenny Djuardi, Michael Christian, Elisa Iskandar, Rahmat Alfian, Roospita Maylasari, Yossi Destani, Adriani Lomiga, Dominikus Minggu, Daphne Lew, Joshua Bogus, Gary J Weil, Peter U Fischer
Published in PLOS Neglected Tropical Diseases (2021)